The deal is expected to close in the second half of 2020, but one analyst expects the transaction will raise antitrust issues in the United States.
The total value of deals for 2019 exceeds $30 billion.
Medical device companies will be driven to evolve their business models to a more patient/consumer-centric approach.
Overall activity in deals jumped 11% in North America.
Despite pricing pressures, several sectors within the medical device industry can expect to enjoy growth and attract attention from investors.